IncellDx, Inc. Signs Deal With Kindstar Global to Offer Novel HPV Technology in China for Cervical Cancer Screening

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MENLO PARK, Calif., 2013-06-11 15:14 CEST (GLOBE NEWSWIRE) -- IncellDx announced today that it has executed an agreement with Kindstar Global, the largest esoteric diagnostic testing service in China, to offer its proprietary laboratory test for the detection of oncogenic HPV E6, E7 mRNA in China. According to the Company, it believes that this agreement will greatly augment its business presence in Asia.

Help employers find you! Check out all the jobs and post your resume.

Back to news